Propecia: Clinically Proven Hair Loss Treatment for Men
Propecia
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.00 | $40.00 (0%) | 🛒 Add to cart |
| 30 | $1.50 | $60.00 $45.00 (25%) | 🛒 Add to cart |
| 60 | $0.92 | $120.00 $55.00 (54%) | 🛒 Add to cart |
| 90 | $0.78 | $180.00 $70.00 (61%) | 🛒 Add to cart |
| 120 | $0.67 | $240.00 $80.00 (67%) | 🛒 Add to cart |
| 180 | $0.61 | $360.00 $110.00 (69%) | 🛒 Add to cart |
| 270 | $0.56 | $540.00 $150.00 (72%) | 🛒 Add to cart |
| 360 | $0.50
Best per pill | $720.00 $180.00 (75%) | 🛒 Add to cart |
Propecia, with the active ingredient finasteride, is a prescription medication specifically developed to treat male pattern hair loss (androgenetic alopecia) in men. It represents a cornerstone of dermatological and trichological practice for addressing this common condition. This oral therapy works systemically to inhibit the conversion of testosterone to dihydrotestosterone (DHT), the primary hormonal driver of follicular miniaturization. By targeting the underlying pathophysiology, Propecia offers a mechanism-based approach to slowing hair loss progression and, in many patients, stimulating regrowth. It is indicated for use in men only and requires a consultation with a healthcare provider to ensure appropriate candidacy.
Features
- Active Pharmaceutical Ingredient: Finasteride 1mg
- Pharmacological Class: Type II 5α-reductase inhibitor
- Dosage Form: Film-coated tablet for oral administration
- Standardized Dosing: A single 1mg strength simplifies the treatment regimen
- Prescription Status: Available only with a valid prescription from a licensed physician
- Manufacturer: Merck & Co., Inc. (or licensed generic equivalents)
Benefits
- Halts the Progression of Hair Loss: The primary clinical benefit is the significant slowing or cessation of the hair loss process in the vast majority of men.
- Promotes Visible Hair Regrowth: A substantial proportion of men treated with finasteride experience regrowth of hair in clinical studies, as measured by hair count and investigator/patient assessments.
- Targets the Root Cause: Functions as a pathogenetic treatment by reducing scalp and serum DHT levels by approximately 60-70%, directly countering the hormonal mechanism of androgenetic alopecia.
- Well-Established Efficacy and Safety Profile: Backed by extensive, multi-year clinical trials and decades of real-world post-marketing surveillance data.
- Convenient Oral Dosing: A once-daily oral tablet integrates easily into most patients’ daily routines, supporting long-term adherence.
- Improves Patient Self-Perception and Quality of Life: Successful treatment is consistently correlated with improved psychosocial outcomes, including reduced anxiety and increased self-esteem related to hair loss.
Common use
Propecia (finasteride 1mg) is exclusively indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men. It is intended for use in men who present with gradual thinning of hair on the vertex (top of the scalp) and anterior mid-scalp area. Its use is predicated on a confirmed diagnosis of androgenetic alopecia by a healthcare professional, typically a dermatologist or trichologist. It is not indicated for use in women or children. Treatment response is not immediate; a minimum of three months of daily therapy is required to assess initial effect on hair loss stabilization, and at least six to twelve months are typically needed to evaluate potential for regrowth. Treatment is considered chronic; continued use is necessary to sustain benefits, as discontinuing therapy leads to a reversal of effect within 12 months.
Dosage and direction
The recommended dosage of Propecia is one 1mg tablet administered orally once daily, with or without food. Adherence to a consistent daily schedule is critical for optimal efficacy. The tablet should be swallowed whole; it should not be crushed or chewed. Patients can be advised that taking the medication at the same time each day (e.g., with breakfast or before bed) may help establish a routine. Clinical studies demonstrate that efficacy is dependent on daily dosing; more frequent administration does not confer additional benefit and is not recommended. As with any chronic therapy, patients should be instructed not to discontinue use without consulting their prescribing physician. A prescription for a 90-day supply is often practical for maintenance therapy.
Precautions
- Pregnancy Warning (Women): Finasteride is contraindicated in women who are or may become pregnant. Tablets are film-coated to minimize risk of handling, but crushed or broken tablets should not be handled by women. The active ingredient can be absorbed through the skin and may cause abnormalities of the external genitalia of a male fetus.
- Required Patient Evaluation: Prior to initiation, a digital rectal exam (DRE) and/or PSA testing should be considered to rule out prostatic carcinoma, as finasteride affects PSA levels.
- Monitoring: Patients should be monitored periodically to assess response to therapy and to reaffirm the continued appropriateness of treatment.
- Prostate Cancer Risk: Finasteride reduces PSA levels by approximately 50%. Any interpreted PSA value in a man taking finasteride should be doubled for comparison to normal ranges. Physicians should be aware of the potential increased risk of high-grade prostate cancer, as identified in the Prostate Cancer Prevention Trial (PCPT) with the 5mg dose; the clinical relevance of this finding for the 1mg dose is uncertain but must be considered.
- Depression and Mood Changes: Patients and prescribers should be alert to the potential for depressive symptoms and other mood alterations. Any new or worsening depression should be reported immediately.
- Physical Examination: A thorough scalp examination and diagnosis should confirm androgenetic alopecia before treatment begins.
Contraindications
Propecia is strictly contraindicated in the following populations:
- Women, especially those who are pregnant or are attempting to conceive.
- Children and adolescents.
- Patients with a known hypersensitivity or allergy to any component of the tablet formulation, including finasteride or inactive ingredients.
- Patients with pre-existing severe hepatic impairment, as the drug is extensively metabolized in the liver.
Possible side effects
Like all medications, Propecia can cause side effects, although not everybody gets them. The following adverse reactions are based on clinical trial data and post-marketing experience, listed by general frequency:
- Sexual Dysfunction (Most Common): Decreased libido (1.8%), erectile dysfunction (1.3%), and ejaculation disorders (e.g., decreased ejaculate volume) (1.2%). These side effects typically occur within the first year of treatment, may resolve with continued therapy in some men, and generally resolve upon discontinuation of the drug.
- Less Common Side Effects: Breast tenderness and enlargement (gynecomastia).
- Rare Side Effects: Allergic reactions, including rash, itching, hives, and swelling of the lips and face; testicular pain; and male infertility and/or poor semen quality that may be reversible upon discontinuation.
- Post-Marketing Reports: Persistence of sexual dysfunction (e.g., erectile dysfunction, loss of libido, ejaculatory disorders) after discontinuation of treatment has been reported; however, the incidence and mechanism are not well understood. Depression and suicidal ideation have also been reported in a small number of cases.
Drug interaction
Formal drug interaction studies have been conducted with Propecia. While no clinically important drug interactions have been identified to date, the potential for interactions exists.
- Theoretically, other 5α-reductase inhibitors (e.g., dutasteride) would be redundant and are not recommended for concomitant use.
- Caution is advised with drugs known to be extensively metabolized by CYP3A4 enzyme systems, as finasteride is metabolized primarily via CYP3A4. Potent inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, ritonavir) could increase finasteride plasma concentrations.
- Patients should provide their physician with a complete list of all prescription, over-the-counter, and herbal products they are taking before starting Propecia.
Missed dose
If a dose is missed, the patient should take it as soon as remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. The patient should not take a double dose to make up for a missed one. Establishing a daily routine minimizes the chance of missed doses.
Overdose
In the event of a suspected overdose, medical attention should be sought immediately. Single doses of finasteride up to 400 mg and multiple doses up to 80 mg/day for three months have been administered without observed adverse effects. Nevertheless, symptomatic and supportive treatment is indicated. Since finasteride is highly protein-bound, it is not expected to be dialyzable.
Storage
Propecia tablets should be stored at room temperature, between 15°C and 30°C (59°F and 86°F). The medication must be kept in its original container to protect it from light and moisture. It should be kept out of reach and sight of children and pets. Do not store in bathrooms or other damp places. Unused medication should be disposed of safely via a medicine take-back program or according to FDA guidelines to prevent accidental ingestion or environmental contamination.
Disclaimer
This product card is for informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on the manufacturer’s prescribing information but may not be exhaustive. Individual patient response and side effects may vary.
Reviews
- Clinical Trial Data (NEJM, 1998): A landmark 2-year, double-blind, placebo-controlled study of 1,553 men demonstrated that finasteride 1mg/day improved hair growth in 66% of men based on investigator assessment, compared to 7% with placebo. Hair count increased by 11% in the finasteride group versus a 5% decrease in the placebo group at 2 years.
- 5-Year Extension Study (J Am Acad Dermatol, 2002): Long-term data showed that finasteride was generally well-tolerated and that hair count in men continued to remain above baseline levels through 5 years of treatment, whereas placebo-treated men showed progressive hair loss.
- Patient Reviews (Aggregate Sites): Patient-reported outcomes are generally positive, with many users reporting stabilization of hair loss and noticeable regrowth after 6-12 months of consistent use. The most frequently cited reason for discontinuation is the experience of sexual side effects, which a minority of users report. Satisfaction is highly correlated with realistic expectations and long-term adherence.